Abstract
Background: Although screening programs in high-risk populations have facilitated the detection of small hepatocellular carcinoma (HCC), some HCC patients continue to present with advanced, large tumors. However, reports of hepatic resection for HCC larger than 10 cm (L-HCC) are limited. This study aims to determine the clinicopathologic factors that influence the prognosis of hepatic resection for L-HCC.
Methods: The clinical features of 211 L-HCC patients undergoing hepatic resection were reviewed. Clinical features and factors influencing the outcome of 985 patients with HCC smaller than 10 cm (S-HCC) were used for comparison.
Results: Of 1196 surgically resected HCCs, 211 (17.6%) were L-HCC. Multivariate logistic regression analysis showed that the presence of dull abdominal pain, a low indocyanine green retention rate value, a high percentage of alfa fetoprotein (AFP) >400 ng/mL, major hepatectomy, absence of tumor capsule formation, satellite lesions, and vascular invasion were the seven main independent factors differentiating L-HCC from S-HCC patients. Significantly worse overall survival was noted in L-HCC patients, especially those with tumor rupture, satellite lesions, AFP >400 ng/mL, and blood loss of >1 L during surgery.
Conclusions: Hepatic resection, when feasible, is safe and is the preferred treatment for L-HCC patients. However, overall and disease-free survival for L-HCC are worse than for S-HCC. Disease-free survival for L-HCC patients undergoing hepatic resection is significantly influenced by a high value of alkaline phosphatase and by AFP. Overall survival for L-HCC patients undergoing hepatic resection is significantly influenced by a high value of AFP, blood loss, tumor rupture, and satellite lesions.
Similar content being viewed by others
REFERENCES
Department of Health, Executive Yuan, Republic of China. Annual Report of Cancer Registration. 2001.
Regimbeau JM, Farges O, Shen BY, Sauvanet A, Belgiti J. Is surgery for large hepatocellular carcinoma justified? J Hepatol 1999;31:1062–8.
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–9.
Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:1121–6.
Livraghi T, Giorgio A, Martin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–8.
Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16:353–7.
Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995;82:122–6.
Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224:4–9.
Noguchi T, Kawarada Y, Kitagawa M, et al. Clinicopathologic factors influencing the long-term prognosis following hepatic resection for large hepatocellular carcinoma more than 10 cm in diameter. Semin Oncol 1997;24:S6–7.
Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790–800.
Lee NH, Chau GY, Lui WY, et al. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10cm in diameter. Br J Surg 1998;85:1654–7.
Furuta T, Sonoda T, Matsumata T, et al. Hepatic resection for a hepatocellular carcinoma larger than 10 cm. J Surg Oncol 1992;51:114–7.
Abdel-Wahab M, Sultan A, el-Ghawalby A, et al. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases. Hepatogastroenterology 2001;48:757–61.
Poon RTP, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter. J Am Coll Surg 2002;194:592–602.
Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic resection for hepatocellular carcinoma in diameter of ≥10 cm. Hepatogastroenterology 2002;19:518–23.
Healey JE, Schroy PC. Anatomy of the biliary ducts within the human liver: analysis of the prevailing pattern of branching and the major variations of the biliary ducts. Arch Surg 1953;66:599–616.
Couinaud C. Le Foie: Etudes Anatomiques et Chirurgicales. Paris: Masson, 1957:187–208.
Edmondsen HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954;7:462–503.
Furuta T, Kanematsu T, Matsumata T, et al. Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 1990;66:2395–8.
Nomura F, Ohnishi K, Nonda M, et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994;70:590–3.
Namieno T, Kawata A, Sato N, et al. Age-related, different clinicopathological features of hepatocellular carcinoma patients. Ann Surg 1995;221:308–14.
Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in young and elderly patients: Taiwan experience. Eur J Surg Oncol 2002;28:652–6.
Ng IOL, Lai ECS, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992;70:45–9.
Yamagata M, Maeda T, Ikeda Y, Shirabe K, Nishizaki T, Koyanagi N. Surgical results of spontaneously ruptured hepatocellular carcinoma. Hepatogastroenterology 1995;42:461–4.
Yeh CN, Chen MF, Lee WC, Jeng LB. Prognosis factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002;81:195–202.
Klompje J, Petrelli NJ, Herrera L, et al. The prognostic value of preoperative alkaline-phosphatase for resection of solitary liver metastasis from colorectal carcinoma. Eur J Surg Oncol 1987;13:345–7.
The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma. A retrospec-tive study of 435 patients. Hepatology 1998;28:751–5.
The Liver Cancer Study of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular in Japan. Cancer 1994;267:257–9.
Murgita RA, Goidl EA, Kontianen S, et al. alpha-Fetoprotein induces suppressor T cells in vitro. Nature 1977;267:257–9.
Yachnin S, Soltani K, Lester EP. Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha-fetoprotein. J Allergy Clin Immunol 1980;65:127–35.
Hanazaki K, Kajikawa S, Foide N, et al. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001;96:1243–50.
Poon TP, Fan ST, Lo CM, Lin CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors. Ann Surg 1999;229:216–22.
Canders DF, Hill GE, Wong KC. Blood transfusion induced immunomodulation. Anesth Analg 1996;82:187–204.
Liu CL, Fan ST, Lo CM, et al. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000;232:25–31.
Yeh CN, Lee WC, Jeng LB, Chen MF. Spontaneous tumor rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg 2002;89:1125–9.
Fan ST, Ng OL, Poon TP, et al. Hepatectomy for hepatocellular carcinoma. The surgeon’s role in long-term survival. Arch Surg 1999;134:1124–30.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeh, CN., Lee, WC. & Chen, MF. Hepatic Resection and Prognosis for Patients With Hepatocellular Carcinoma Larger Than 10 cm: Two Decades of Experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10, 1070–1076 (2003). https://doi.org/10.1245/ASO.2003.03.072
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.03.072